Cleared Traditional

MORELLE SOS TREATMENT, MORELLE MAMAPLAST, MORELLE ABDOPLAST (K933811) - FDA 510(k) Clearance

Class I General & Plastic Surgery device.

K933811 · Pitt Enterprises (Silicone) , Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1994
Decision
281d
Days
Class 1
Risk

K933811 is an FDA 510(k) clearance for the MORELLE SOS TREATMENT, MORELLE MAMAPLAST, MORELLE ABDOPLAST. Classified as Elastomer, Silicone, For Scar Management (product code MDA), Class I - General Controls.

Submitted by Pitt Enterprises (Silicone) , Ltd. (New Millford, US). The FDA issued a Cleared decision on May 12, 1994 after a review of 281 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4025 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Pitt Enterprises (Silicone) , Ltd. devices

Submission Details

510(k) Number K933811 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 1993
Decision Date May 12, 1994
Days to Decision 281 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
166d slower than avg
Panel avg: 115d · This submission: 281d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code MDA Elastomer, Silicone, For Scar Management
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4025
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.